Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review

Shuangqiu Wang,1– 3,* Jiarui Ma,4,* Yanqi Zeng,5,* Guowei Zhou,6 Yuxuan Wang,1– 3 Wenjuan Zhou,5 Xiaohe Sun,5 Minghua Wu1,5 1Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029,...

Full description

Bibliographic Details
Main Authors: Wang S, Ma J, Zeng Y, Zhou G, Wang Y, Zhou W, Sun X, Wu M
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/icariin-an-up-and-coming-bioactive-compound-against-neurological-disea-peer-reviewed-fulltext-article-DDDT
id doaj-375c6c7801604685a76df4773c6e4eb0
record_format Article
spelling doaj-375c6c7801604685a76df4773c6e4eb02021-08-22T20:34:14ZengDove Medical PressDrug Design, Development and Therapy1177-88812021-08-01Volume 153619364168041Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature ReviewWang SMa JZeng YZhou GWang YZhou WSun XWu MShuangqiu Wang,1– 3,* Jiarui Ma,4,* Yanqi Zeng,5,* Guowei Zhou,6 Yuxuan Wang,1– 3 Wenjuan Zhou,5 Xiaohe Sun,5 Minghua Wu1,5 1Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, People’s Republic of China; 2Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, 210046, People’s Republic of China; 3State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210046, Jiangsu, People’s Republic of China; 4Provincial Key Laboratory of Drug Target and Drug for Degenerative Disease, School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210046, Jiangsu, People’s Republic of China; 5First Clinical Medical School, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210046, Jiangsu, People’s Republic of China; 6Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Minghua WuDepartment of Neurology, Jiangsu Provincial Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Qinhuai District, Nanjing, Jiangsu, People’s Republic of ChinaTel +86-13951786719Fax +86 25 8661 7141Email mhuawu@163.comAbstract: Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe the active chemical components of Epimedii herba; and examine the evidence from experimental studies that have uncovered molecular targets of icariin in different diseases. We also constructed a protein–protein interaction network and carried out Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to predict the therapeutic actions of icariin in nervous system diseases including Alzheimer disease, Parkinson disease, ischemic stroke, depressive disorder, multiple sclerosis, glioblastoma, and hereditary spastic paraplegias. The results of our analyses can guide future studies on the application of icariin to the treatment of neurologic disorders.Keywords: Epimedii herba, icariin, network pharmacology, literature review, nervous system diseaseshttps://www.dovepress.com/icariin-an-up-and-coming-bioactive-compound-against-neurological-disea-peer-reviewed-fulltext-article-DDDTepimedii herbaicariinnetwork pharmacologyliterature reviewnervous system diseases
collection DOAJ
language English
format Article
sources DOAJ
author Wang S
Ma J
Zeng Y
Zhou G
Wang Y
Zhou W
Sun X
Wu M
spellingShingle Wang S
Ma J
Zeng Y
Zhou G
Wang Y
Zhou W
Sun X
Wu M
Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
Drug Design, Development and Therapy
epimedii herba
icariin
network pharmacology
literature review
nervous system diseases
author_facet Wang S
Ma J
Zeng Y
Zhou G
Wang Y
Zhou W
Sun X
Wu M
author_sort Wang S
title Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_short Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_full Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_fullStr Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_full_unstemmed Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_sort icariin, an up-and-coming bioactive compound against neurological diseases: network pharmacology-based study and literature review
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2021-08-01
description Shuangqiu Wang,1– 3,* Jiarui Ma,4,* Yanqi Zeng,5,* Guowei Zhou,6 Yuxuan Wang,1– 3 Wenjuan Zhou,5 Xiaohe Sun,5 Minghua Wu1,5 1Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, People’s Republic of China; 2Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, 210046, People’s Republic of China; 3State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210046, Jiangsu, People’s Republic of China; 4Provincial Key Laboratory of Drug Target and Drug for Degenerative Disease, School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210046, Jiangsu, People’s Republic of China; 5First Clinical Medical School, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210046, Jiangsu, People’s Republic of China; 6Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Minghua WuDepartment of Neurology, Jiangsu Provincial Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Qinhuai District, Nanjing, Jiangsu, People’s Republic of ChinaTel +86-13951786719Fax +86 25 8661 7141Email mhuawu@163.comAbstract: Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe the active chemical components of Epimedii herba; and examine the evidence from experimental studies that have uncovered molecular targets of icariin in different diseases. We also constructed a protein–protein interaction network and carried out Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to predict the therapeutic actions of icariin in nervous system diseases including Alzheimer disease, Parkinson disease, ischemic stroke, depressive disorder, multiple sclerosis, glioblastoma, and hereditary spastic paraplegias. The results of our analyses can guide future studies on the application of icariin to the treatment of neurologic disorders.Keywords: Epimedii herba, icariin, network pharmacology, literature review, nervous system diseases
topic epimedii herba
icariin
network pharmacology
literature review
nervous system diseases
url https://www.dovepress.com/icariin-an-up-and-coming-bioactive-compound-against-neurological-disea-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT wangs icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT maj icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT zengy icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT zhoug icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT wangy icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT zhouw icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT sunx icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT wum icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
_version_ 1721199082069819392